Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer

To determine the efficacy and tolerability of SPI-77 (sterically stabilised liposomal cisplatin) at three dose levels in patients with advanced non-small-cell lung cancer (NSCLC). Patients had Stage IIIB or IV NSCLC and were chemo-naïve, and Eastern Oncology Cooperative Group 0–2. The first cohort r...

詳細記述

保存先:
書誌詳細
主要な著者: White, S C, Lorigan, P, Margison, G P, Margison, J M, Martin, F, Thatcher, N, Anderson, H, Ranson, M
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2006
主題:
Clinical Study
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360546/
https://ncbi.nlm.nih.gov/pubmed/16969346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603345
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料